Stay updated on Safety and Efficacy of BI 695500 in Rheumatoid Arthritis Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy of BI 695500 in Rheumatoid Arthritis Clinical Trial page.

Latest updates to the Safety and Efficacy of BI 695500 in Rheumatoid Arthritis Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3; no visible changes to study information.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check40 days agoChange DetectedA government funding status notice has been added to the page. The software version has been updated to v3.4.1, and the previous version tag v3.4.0 was removed.SummaryDifference0.4%

- Check47 days agoChange DetectedGlossary is now shown, and several metadata labels have been updated (e.g., capitalization of 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data') along with the revision label updated to v3.4.0.SummaryDifference0.2%

- Check61 days agoChange DetectedFooter revision badge updated from v3.3.3 to v3.3.4 on the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedLocations were added/restructured to list study sites by state (Alabama, Arizona, Arkansas, California, Florida, Illinois, Maryland, Massachusetts, Michigan, Nebraska, New Jersey, New York, North Carolina, Ohio, Tennessee, Texas, West Virginia) and a page Revision: v3.3.3 was included.SummaryDifference2%

Stay in the know with updates to Safety and Efficacy of BI 695500 in Rheumatoid Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of BI 695500 in Rheumatoid Arthritis Clinical Trial page.